Type 2 Idiopathic Macular Telangiectasia
1 clinical trials · Condition
◉ Watch Type 2 Idiopathic Macular Telangiectasia
| Record | Firm | Date |
|---|---|---|
| Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial) (NCT00504400) | University Hospital, Bonn | 2007-08-01 |
Track Type 2 Idiopathic Macular Telangiectasia automatically
Every clearance here is in the API, with alerts when new ones post.